Enzo Health Technology, Inc.

Enzo Health Technology, Inc. is a US-based firm dedicated to providing innovative AI-driven documentation solutions that enhance efficiency and compliance in the home health care sector. Founded in 2023 and headquartered in Lehi, US, Enzo Health specializes in AI documentation solutions for home health agencies. The company has completed 2 deals and raised USD 6.

00 mn in its latest funding round from Gradient Ventures, Rigby Watts & Company, and Tandem, bringing the total amount raised to USD 6. 00 mn. Enzo Health provides an integrated suite of home health AI documentation solutions designed to enhance workflow efficiency and compliance in the home health care sector. Their core offerings include Enzo Scribe, which facilitates real-time OASIS validation within assessments to mitigate denial risks and streamline coding processes, and Enzo Intake, which automates referral analysis to identify coverage, eligibility, and data gaps before human intervention.

Additionally, Enzo QA employs built-in clinical and regulatory guardrails to catch documentation issues proactively, ensuring compliance and optimizing reimbursement outcomes. These solutions are tailored for home health agencies, clinicians, and healthcare administrators, primarily targeting markets in the United States. Enzo Health’s technology enhances clinician-patient interactions, allowing clinicians to document care efficiently while maintaining patient engagement. Enzo Health’s revenue model is primarily subscription-based, characterized by a structured approach that allows clients to access their suite of products through recurring fees.

Clients, which include home health agencies, pay for services such as Enzo Scribe, Enzo Intake, and Enzo QA, gaining access to features that improve operational efficiency and documentation accuracy. The company’s pricing plans are designed for flexibility to accommodate the varying needs of home health providers, and are structured to enable agencies to scale their services as they grow. By leveraging these AI-driven tools, agencies can increase patient throughput without necessarily expanding their workforce, thereby enhancing their revenue capture significantly through improved coding accuracy and compliance with Medicare regulations. Enzo Health plans to utilize the recently raised USD 6.

00 mn in venture funding to enhance its product offerings and expand into new geographic markets. The company is currently designing new features for its existing solutions, with anticipated releases aimed at bolstering operational efficiencies for home health providers. In addition to its ongoing developments, Enzo Health is targeting expansion into additional regions of the United States to increase its market presence and client base. In May 2026, Enzo Health raised USD 20 million in series A funding led by new investor N47, with participation from other new investors Lionel Partners and Soma Capital Management.

Returning investors Rigby Watts & Company, Gradient Ventures, and Tandem also participated in the round. The company will use the May 2026 funding to deploy AI across home health and post‑acute care and fund expansion into skilled nursing and hospice care while scaling its platform across clinical, operational, and billing workflows.